Transcranial Stimulation Electrode Enclosure with Conductive Fluid
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current transcranial direct current stimulation (tDCS) systems are limited by the potential for tissue damage and restricted application time due to direct electrode contact with the skin, which restricts the duration and power of electrical current delivery.
Innovation Solution
A system with electrodes positioned within an enclosure spaced from the skin, using conductive fluid to apply low frequency oscillatory or direct current to the brain, shielding the electrode from tissue contact and allowing for longer and higher power applications without collateral damage or excessive Faradic product concentration.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Ease of operation
If electrodes are placed directly on the scalp for tDCS, then current delivery is simple and direct, but tissue damage and excessive Faradic product concentration occur limiting application time and power
Solution Approach 1:
The patent introduces an intermediary conductive gel medium between the electrode and the scalp. This gel serves as a mediator that allows electrical current to pass through while preventing direct harmful contact between the electrode and tissue, thereby reducing tissue damage and controlling Faradic product concentration at the tissue interface.
Solution Approach 2:
The patent employs a flexible electrode cap or interface layer that distributes current more evenly across the scalp surface. This flexible interface acts as a protective barrier that prevents concentrated current density from damaging the underlying tissue while still allowing effective current delivery for neural modulation.
2Power
If higher power levels are applied for longer durations to improve treatment efficacy, then neuronal modulation effectiveness increases, but tissue damage risk increases
Solution Approach 1:
The patent implements protective measures in advance by using a conductive gel interface and optimized electrode design that cushion against potential tissue damage before it occurs. This pre-protective approach allows the system to safely deliver higher power levels for extended durations by preventing the accumulation of harmful effects at the tissue-electrode interface.
3Duration of action of moving object
If application time is extended to improve treatment outcomes, then neuronal modulation effectiveness increases, but Faradic product concentration becomes excessive causing tissue damage
Solution Approach 1:
The conductive gel acts as an intermediary buffer that accumulates Faradic products away from the tissue interface during extended stimulation sessions. This mediator allows prolonged current delivery by capturing harmful electrochemical byproducts before they can concentrate at the sensitive tissue boundary, thereby enabling longer treatment durations without excessive Faradic product accumulation.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
Enables safer and more effective modulation of neuronal activity for extended periods, reducing tissue damage risks and allowing for higher power levels, thereby improving treatment efficacy for neurological disorders such as schizophrenia and depression.
Implementation Method 1
using conductive fluid to apply low frequency oscillatory or direct current to the brain
Implementation Method 2
shielding the electrode from tissue contact and allowing for longer and higher power applications without collateral damage or excessive Faradic product concentration
Data Source
AI summary
Systems, apparatus and methods are described for applying electric current to neurons in the brain to treat disorders and to improve motor and/or memory functions in a patient. In a method according to the invention, an electrode is positioned adjacent to and spaced from the skin surface of the patient's head and an electric current is applied through the electrode to a target region in the brain to modulate one or more neurons in the target region. The electrode is housed within an enclosure and spaced from the skin surface so that the electrode does not directly contact the patient's tissue, which reduces the potential for collateral tissue damage or necrosis and shields the electrode from the patient's tissue which substantially inhibits Faradic products (e.g., H+, OH−, H2O2) of the electrode from reaching the target site.


